DEPT. OF CORRECTIONS
DEPT. OF CORRECTIONS: Beecham: Charles Kapp, president of Beecham Western Hemisphere Pharmaceutical Division, is retiring Oct. 1 after 21 years with the company, not resigning ("The Pink Sheet" Aug. 29, In Brief).
You may also be interested in...
No device-related warning letters were released by the US FDA the week of 29 September.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
Durable responses have continued to be seen two years after administration of Sarepta’s candidate gene therapy to four boys with Duchenne muscular dystrophy.